載入...
Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin
Aim: Glucagon-like peptide-1 can reduce both postprandial plasma glucose (PG) and chylomicron (CM) levels in patients with type 2 diabetes. However, there have been no reports regarding the relationship between the postprandial metabolism of PG and CM. Methods: Patients with type 2 diabetes who were...
Na minha lista:
| 發表在: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Japan Atherosclerosis Society
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5305676/ https://ncbi.nlm.nih.gov/pubmed/27397060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.32409 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|